AI in Clinical Trials Market: Digital Transformation Accelerates Clinical Trial Innovation
The AI in Clinical Trials Market is entering a technology-driven phase as stakeholders focus on shorter enrollment periods, higher data quality, predictive insights, reduced trial failures, and scalable AI platforms that enhance overall clinical research efficiency. According to Business Market Insights, the AI in Clinical Trials Market size was valued at US$ 4.10 Billion in 2025 and is projected to reach US$ 60.77 Billion by 2033, growing at a CAGR of 40.08% during 2026–2033. Strategic Framework The strategic framework for the AI in Clinical Trials Market centers on the convergence of artificial intelligence, clinical research data, cloud computing, precision medicine, and decentralized trial models. Pharmaceutical organizations are increasingly seeking integrated platforms that can connect fragmented clinical datasets and automate resource-intensive processes. Software/platforms represent the leading offering segment, accounting for approximately 61%–64% of market share ...